Manipal Health Enterprises Limited
IPO Details
Subscription
Lot Distribution
Reservation
Company Fin.
₹-10(-1.69%)
Premium (ELP)
Subscription for Manipal Health Enterprises Limited's Initial Public Offering is currently underway, targeting total proceeds of 15,72,33,715 Shares. The offering composition includes 13,56,19,881 Shares in new capital infusion and ₹1275.22 Cr in existing shareholder sales.
The active price band of ₹560 to ₹590 and minimum lot requirement of 25 shares define the current investment parameters. Market participants are actively evaluating this opportunity during the subscription window.
The application deadline is fast approaching on Jul 31, 2026. Following Subscription closure, allotment will be processed on Aug 03, 2026, leading to the anticipated listing on Aug 05, 2026 at the NSE, BSE exchange platform.
Investors can bid starting from the minimum lot size specified for this IPO, and only in multiples of that lot size. The table below shows the minimum and maximum investment for retail investors and HNIs in terms of lots, quantity, and amount.
Manipal Health Enterprises Limited is a leading healthcare service provider in India and part of the Manipal Group, founded by T. M. A. Pai, operating a wide network of multi-specialty hospitals, clinics, and diagnostic centers across the country. The company offers a broad range of medical services including tertiary and quaternary care, organ transplants, oncology, cardiology, neurology, orthopaedics, and preventive healthcare, supported by advanced technology and experienced medical professionals. It focuses on delivering quality, patient-centric care while expanding its reach through acquisitions, partnerships, and investments in infrastructure and digital health. As of September 30, 2025, the company operated 38 hospitals (48 on a
Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."
The expected premium is based on market buzz and online information. It should not be considered as the actual listing price or valuation. Always refer to the RHP and seek advice from a financial expert before making any investment decisions.
- Advanced Healthcare Infrastructure: The company operates modern hospitals equipped with advanced medical technology, providing high-quality healthcare services across multiple specialties.
- Experienced Leadership Team: It is led by an experienced management team with strong institutional backing, supporting stable operations and long-term growth.
- Strong Presence in Key Cities: The company has a leading position in major markets such as Bengaluru, Kolkata, and Pune, supported by a well-balanced hospital network across India.
- Dependence on Inpatient Revenue: A large portion of the company's revenue comes from inpatient services. Lower patient admissions or occupancy levels may affect revenue and profitability.
- Healthcare & Regulatory Risk: The company operates in a highly regulated industry and may face legal, operational, or regulatory challenges that could impact business performance.
- Medical Negligence Risk: Claims related to treatment quality, medical negligence, pricing disputes, or healthcare services could lead to legal liabilities and reputational damage.
- Dr. Ranjan Ramdas Pai
- Manipal Global Health Services
- Memg International Ltd
- Kangto Investments Pte. Ltd.
- Imperius Healthcare Investments Pte. Ltd.
- Kabru Investments Pte. Ltd.
Manipal Health Enterprises Limited
Kfin Technologies Limited